These results uncover a new mechanism of p53 inactivation providing an interesting novel molecular link between metabolic diseases such as diabetes or obesity and tumor progression and resistance to therapies. The gene discussed is TP53; the disease is obesity due to melanocortin 4 receptor deficiency.